LIPID BIOMARKERS FOR DIABETIC COMPLICATIONS
糖尿病并发症的脂质生物标志物
基本信息
- 批准号:7892535
- 负责人:
- 金额:$ 54.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAdultAffectAnimal ModelAtherosclerosisBiological AssayBiological MarkersBloodBlood CellsBlood PlateletsBody mass indexCarbohydratesCardiacCardiac MyocytesCardiomyopathiesCardiovascular systemCaringClinicalComplicationComplications of Diabetes MellitusCoronary ArteriosclerosisDataDiabetes MellitusDiagnosisDiastolic heart failureDietDiseaseEarly DiagnosisErythrocytesFatty AcidsFatty acid glycerol estersFunctional disorderGoalsHeartHeart DiseasesHeart failureImageIndividualLeadLinkLipidsMagnetic Resonance SpectroscopyMeasuresMedicineMembrane LipidsMetabolismMyocardialMyocardiumNicotinic AcidsNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsObesityPathogenesisPatientsPeripheralPhenotypePhysicsPhysiologicalPlasmaPlayPopulationPreventionRadiology SpecialtyRecruitment ActivityReproducibilityRiskRoleScientistSpectrometry, Mass, Electrospray IonizationStructureStudy SubjectSumTestingTimeTissuesTriglyceridesTwo-Dimensional Doppler EchocardiographyUniversitiesVariantWashingtonWeightWomanacipimoxanalogbasediabeticdiabetic cardiomyopathydiabetic patientfatty acid metabolismfeedingheart functionheart imaginghigh riskhuman subjectimprovedinsightinsulin sensitivitylipid metabolismmenmultidisciplinarynovelnovel therapeuticsoral glucose tolerancepreventpublic health relevancetooltwo-dimensionalworking group
项目摘要
DESCRIPTION (provided by applicant): Diabetes is associated with serious cardiovascular complications that include heart failure. Data from studies conducted in animal models and human subjects suggest that alterations in fatty acid metabolism, independent of atherosclerosis, are involved in the pathogenesis of heart failure in diabetic cardiomyopathy. This study will test the overall hypothesis that excessive myocardial fatty acid delivery and utilization is associated with cardiomyopathy in patients who have type 2 diabetes mellitus. Moreover, we hypothesize that alterations in lipid metabolism can be exploited to develop novel biomarkers for early detection of myocardial lipid exposure and diabetic cardiomyopathy. To test these hypotheses, we will study the relationship between fatty acid metabolism, lipid biomarkers and cardiac function in carefully characterized men and women who span physiological and pathophysiological ranges in insulin sensitivity, plasma lipid biomarkers and cardiac function. The goals of this study are to 1) identify novel plasma biomarkers for early detection and management of diabetic cardiomyopathy; and 2) determine whether manipulations of fatty acid delivery to the heart affect the functional manifestations of diabetic cardiomyopathy. This study will provide a better understanding of the relationship between systemic and myocardial fatty acid metabolism and cardiac function, which could also lead to new strategies for diagnosis, prevention, and treatment of diabetic cardiomyopathy. PUBLIC HEALTH RELEVANCE: Diabetes is associated with serious cardiovascular complications including heart failure that is unrelated to coronary artery disease. Scientific evidence suggests that blood fat levels may play a major role in this complication. Our study will investigate the link between blood fat levels and heart function in adults with type 2 diabetes. Our goal is to develop new blood-based biomarkers of heart disease in diabetics and to provide insight into new therapeutic strategies.
描述(由申请人提供):糖尿病与严重的心血管并发症有关,包括心力衰竭。在动物模型和人类受试者中进行的研究数据表明,脂肪酸代谢的改变,独立于动脉粥样硬化,参与糖尿病心肌病心力衰竭的发病机制。本研究将检验心肌脂肪酸输送和利用过度与2型糖尿病患者心肌病相关的总体假设。此外,我们假设脂质代谢的改变可以用来开发新的生物标志物,用于早期检测心肌脂质暴露和糖尿病心肌病。为了验证这些假设,我们将研究脂肪酸代谢,脂质生物标志物和心脏功能之间的关系,在仔细表征的男性和女性谁跨越生理和病理生理范围的胰岛素敏感性,血脂生物标志物和心脏功能。本研究的目标是:1)识别新型血浆生物标志物,用于糖尿病心肌病的早期检测和治疗; 2)确定脂肪酸输送到心脏的操作是否影响糖尿病心肌病的功能表现。本研究将有助于更好地了解全身和心肌脂肪酸代谢与心功能的关系,也可能为糖尿病心肌病的诊断、预防和治疗提供新的策略。公共卫生关系:糖尿病与严重的心血管并发症有关,包括与冠状动脉疾病无关的心力衰竭。科学证据表明,血脂水平可能在这种并发症中起主要作用。我们的研究将调查成人2型糖尿病患者血脂水平和心脏功能之间的联系。我们的目标是开发新的基于血液的糖尿病心脏病生物标志物,并提供新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL S ORY其他文献
DANIEL S ORY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL S ORY', 18)}}的其他基金
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-皮克 C 病的氧甾醇生物标志物
- 批准号:
9069134 - 财政年份:2013
- 资助金额:
$ 54.65万 - 项目类别:
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-皮克 C 病的氧甾醇生物标志物
- 批准号:
8658869 - 财政年份:2013
- 资助金额:
$ 54.65万 - 项目类别:
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-匹克 C 病的氧甾醇生物标志物
- 批准号:
9281925 - 财政年份:2013
- 资助金额:
$ 54.65万 - 项目类别:
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE
尼曼-皮克 C 病的氧甾醇生物标志物
- 批准号:
8593643 - 财政年份:2013
- 资助金额:
$ 54.65万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
7912069 - 财政年份:2010
- 资助金额:
$ 54.65万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8444326 - 财政年份:2010
- 资助金额:
$ 54.65万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8274949 - 财政年份:2010
- 资助金额:
$ 54.65万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8095515 - 财政年份:2010
- 资助金额:
$ 54.65万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8225176 - 财政年份:2010
- 资助金额:
$ 54.65万 - 项目类别:
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS
非编码 RNA 调节胆固醇稳态
- 批准号:
8049125 - 财政年份:2010
- 资助金额:
$ 54.65万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 54.65万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 54.65万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 54.65万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 54.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 54.65万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 54.65万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 54.65万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 54.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 54.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 54.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




